Sarah Watson

4.4k total citations
73 papers, 1.5k citations indexed

About

Sarah Watson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sarah Watson has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Sarah Watson's work include Sarcoma Diagnosis and Treatment (30 papers), Cardiac tumors and thrombi (11 papers) and Vascular Tumors and Angiosarcomas (8 papers). Sarah Watson is often cited by papers focused on Sarcoma Diagnosis and Treatment (30 papers), Cardiac tumors and thrombi (11 papers) and Vascular Tumors and Angiosarcomas (8 papers). Sarah Watson collaborates with scholars based in France, United States and United Kingdom. Sarah Watson's co-authors include Franck Tirode, Jean‐Michel Coindre, François Le Loarer, Gaëlle Pierron, Mabel Jouve, Philippe Benaroch, Nathalie Sol‐Foulon, Olivier Delattre, Olivier Schwartz and Lee M. Ellis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Sarah Watson

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Watson France 18 618 523 419 238 170 73 1.5k
Shyh‐Han Tan United States 28 701 1.1× 1.3k 2.5× 614 1.5× 277 1.2× 211 1.2× 67 2.7k
Daron Smith United Kingdom 23 592 1.0× 1.5k 2.8× 1.2k 2.8× 166 0.7× 99 0.6× 81 2.9k
Rosemary Wieczorek United States 23 239 0.4× 460 0.9× 820 2.0× 598 2.5× 151 0.9× 69 2.1k
Brian J. O’Hara United States 19 274 0.4× 979 1.9× 243 0.6× 178 0.7× 128 0.8× 46 2.0k
S. Meehan United States 24 326 0.5× 381 0.7× 750 1.8× 290 1.2× 267 1.6× 216 2.5k
Mike Griffiths United Kingdom 33 250 0.4× 920 1.8× 332 0.8× 233 1.0× 84 0.5× 73 2.8k
Bruce Allen Bach United States 25 600 1.0× 499 1.0× 659 1.6× 169 0.7× 292 1.7× 57 2.7k
Carlos Urmacher United States 29 786 1.3× 252 0.5× 1.1k 2.6× 371 1.6× 157 0.9× 66 2.7k
Marc K. Wallack United States 23 198 0.3× 373 0.7× 829 2.0× 137 0.6× 90 0.5× 109 2.0k
Rosmarie Caduff Switzerland 28 180 0.3× 589 1.1× 384 0.9× 482 2.0× 55 0.3× 68 2.3k

Countries citing papers authored by Sarah Watson

Since Specialization
Citations

This map shows the geographic impact of Sarah Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Watson more than expected).

Fields of papers citing papers by Sarah Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Watson. The network helps show where Sarah Watson may publish in the future.

Co-authorship network of co-authors of Sarah Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Watson. A scholar is included among the top collaborators of Sarah Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Watson. Sarah Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vanacker, Hélène, Nicolas Penel, Sarah Watson, et al.. (2025). Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study. Cancer. 131(18). e70052–e70052. 1 indexed citations
3.
Wolfe, Kelly R., et al.. (2025). Cognitive Outcomes and Delirium After Cardiac Neurodevelopmental Program Implementation for Children With Congenital Heart Disease. JAMA Network Open. 8(1). e2456324–e2456324. 3 indexed citations
4.
5.
6.
Collaud, Stéphane, Theresa Störk, Dagmar Adámková Krákorová, et al.. (2024). 1732P Primary pulmonary sarcoma: A EURACAN project. Annals of Oncology. 35. S1037–S1037.
7.
Bonvalot, Sylvie, Nathalie Cozic, Axel Le Cesne, et al.. (2023). Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial. Annals of Surgical Oncology. 30(13). 8653–8659. 12 indexed citations
8.
Tzanis, Dimitri, Toufik Bouhadiba, Sylvie Helfré, et al.. (2023). Diagnostic accuracy and safety of percutaneous core needle biopsy of retroperitoneal tumours. European Journal of Surgical Oncology. 50(1). 107298–107298. 3 indexed citations
9.
Watson, Sarah, Collette A. LaVigne, Lin Xu, et al.. (2023). VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis. Cell Reports. 42(1). 112013–112013. 9 indexed citations
10.
Zagorščak, Renato, et al.. (2022). Risk assessment methodology for Underground Coal Gasification technology. Journal of Cleaner Production. 370. 133493–133493. 6 indexed citations
11.
Cidre‐Aranaz, Florencia, Sarah Watson, James F. Amatruda, et al.. (2022). Small round cell sarcomas. Nature Reviews Disease Primers. 8(1). 66–66. 19 indexed citations
12.
Blay, Jean‐Yves, Antoine Italiano, Nicolas Penel, et al.. (2022). 1316O Improved nationwide survival of sarcoma patients 10 years after establishment of the NETSARC+ reference center network. Annals of Oncology. 33. S1145–S1146. 2 indexed citations
13.
Pierron, Gaëlle, Nadège Gruel, Delphine Guillemot, et al.. (2021). Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics). Journal of Molecular Diagnostics. 23(10). 1380–1392. 17 indexed citations
14.
Watson, Sarah. (2021). Nouveautés sur la caractérisation moléculaire des sarcomes des tissus mous. Bulletin du Cancer. 108(6). 654–667. 1 indexed citations
15.
Mir, Olivier, Sarah Watson, & Jean‐Yves Blay. (2020). Letter: Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era. Neurosurgery. 86(5). E480–E482. 2 indexed citations
16.
Mir, Olivier, Sarah Watson, Christophe Massard, et al.. (2020). Sequential treatment with NOTCH inhibitor crenigacestat followed by pazopanib in soft tissue sarcoma patients. Annals of Oncology. 31(12). 1782–1784. 3 indexed citations
17.
Gramont, Armand de, Sarah Watson, Lee M. Ellis, et al.. (2014). Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nature Reviews Clinical Oncology. 12(4). 197–212. 130 indexed citations
18.
Watson, Sarah, et al.. (2011). MET : nouvelle cible, nouvelles approches combinatoires. Bulletin du Cancer. 98(6). 689–696. 1 indexed citations
19.
Watson, Sarah, et al.. (2010). [Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies].. PubMed. 97(12). 1477–83. 5 indexed citations
20.
Grigorov, Boyan, Sarah Watson, Claudine Pique, et al.. (2009). A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology. 6(1). 28–28. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shyh‐Han Tan Breakdown of academic impact, for papers by Daron Smith Breakdown of academic impact, for papers by Rosemary Wieczorek Breakdown of academic impact, for papers by Brian J. O’Hara Breakdown of academic impact, for papers by S. Meehan Breakdown of academic impact, for papers by Mike Griffiths Breakdown of academic impact, for papers by Bruce Allen Bach Breakdown of academic impact, for papers by Carlos Urmacher Breakdown of academic impact, for papers by Marc K. Wallack Breakdown of academic impact, for papers by Rosmarie Caduff
Rankless by CCL
2026